Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?
Relmada Therapeutics Ownership Summary
Relmada Therapeutics is owned by 42.04% institutional investors, 10.75% insiders, and 47.21% retail investors. Ikarian capital is the largest institutional shareholder, holding 5.55% of RLMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.57% of its assets in Relmada Therapeutics shares.
RLMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relmada Therapeutics | 42.04% | 10.75% | 47.21% |
| Sector | Healthcare Stocks | 231.98% | 10.74% | -142.72% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
| Idea | Psychedelic Stocks List | 20.20% | 9.72% | 70.08% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ikarian capital | 1.84M | 5.55% | $3.70M |
| Blackrock funding, inc. /de | 1.27M | 3.82% | $6.12M |
| Vanguard group | 1.20M | 3.63% | $5.81M |
| Geode capital management | 854.93K | 2.58% | $4.13M |
| Driehaus capital management | 740.01K | 2.23% | $1.49M |
| Boothbay fund management | 693.24K | 2.09% | $1.39M |
| Blackrock | 573.31K | 1.90% | $1.72M |
| Acadian asset management | 526.72K | 1.59% | $2.54M |
| Advisorshares investments | 319.51K | 0.96% | $1.54M |
| Marshall wace, llp | 272.05K | 0.82% | $546.83K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ikarian capital | 1.84M | 0.37% | $3.70M |
| Advisorshares investments | 319.51K | 0.26% | $1.54M |
| Apricus wealth | 47.46K | 0.12% | $229.24K |
| Eam investors | 162.55K | 0.09% | $785.13K |
| Parsons capital management inc/ri | 263.00K | 0.07% | $1.27M |
| Pandora wealth | 20.00K | 0.06% | $96.60K |
| Spotlight asset group | 20.00K | 0.04% | $60.00K |
| Boothbay fund management | 693.24K | 0.02% | $1.39M |
| Rbf capital | 163.26K | 0.01% | $328.15K |
| Driehaus capital management | 740.01K | 0.01% | $1.49M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ikarian capital | 1.84M | 0.37% | 1.80M |
| Vanguard group | 1.20M | 0.00% | 784.73K |
| Blackrock funding, inc. /de | 1.27M | 0.00% | 759.50K |
| Boothbay fund management | 693.24K | 0.02% | 693.24K |
| Geode capital management | 854.93K | 0.00% | 558.72K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -674.83K |
| Palo alto investors lp | - | - | -495.15K |
| Vestal point capital, lp | - | - | -490.00K |
| Opaleye management | - | - | -480.00K |
| Millennium management | 64.36K | 0.00% | -277.09K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Boothbay fund management | 693.24K | 0.02% | 693.24K | $1.39M |
| Eam investors | 162.55K | 0.09% | 162.55K | $785.13K |
| Goldman sachs group | 145.00K | 0.00% | 145.00K | $700.35K |
| Sei investments | 98.97K | 0.00% | 98.97K | $478.00K |
| Jefferies financial group | 21.66K | 0.00% | 21.66K | $104.59K |
Sold Out
| Holder | Change |
|---|---|
| Blackston financial advisory group | -2.00 |
| Innealta capital | -5.00 |
| Smartleaf asset management | -35.00 |
| Qube research | -56.00 |
| Larson financial group | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 43 | -4.44% | 13,954,173 | 80.30% | 42 | 7.73% | 22 | 37.50% | 8 | -27.27% |
| Sep 30, 2025 | 44 | -8.33% | 7,739,578 | 45.94% | 23 | 9.13% | 16 | -5.88% | 10 | -23.08% |
| Jun 30, 2025 | 47 | 6.82% | 5,303,149 | -14.73% | 15 | 3.82% | 17 | 41.67% | 12 | -14.29% |
| Mar 31, 2025 | 44 | -15.38% | 6,219,493 | -25.95% | 20 | 2.64% | 12 | -36.84% | 14 | -33.33% |
| Dec 31, 2024 | 20 | -73.68% | 5,351,011 | -56.77% | 17 | 1.05% | 6 | -70.00% | 8 | -68.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 851.92K | 2.57% | - |
| Vanguard Total Stock Mkt Idx Inv | 803.29K | 2.42% | -48.63K |
| Biotech Growth Ord | 1.52M | 2.07% | 1.52M |
| Franklin Biotechnology Discv A(acc)USD | 623.80K | 2.07% | -221.90K |
| Franklin Biotechnology Discovery A | 336.31K | 1.11% | -120.09K |
| Vanguard Institutional Extnd Mkt Idx Tr | 798.97K | 1.09% | 1.61K |
| Horizons Psychedelic Stock ETF | 227.04K | 0.75% | -36.13K |
| Fidelity Extended Market Index | 389.86K | 0.53% | 248.12K |
| AdvisorShares Psychedelics ETF | 338.87K | 0.46% | - |
| Bridgeway Ultra-Small Company | 100.18K | 0.33% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 15, 2025 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $113.30K |
| Dec 15, 2025 | Shenouda Maged | Chief Financial Officer | Buy | $48.06K |
| Nov 05, 2025 | Shenouda Maged | Chief Financial Officer | Buy | $1.10M |
| Nov 05, 2025 | Ence Chuck | CAO and COO | Buy | $299.20K |
| Nov 05, 2025 | TRAVERSA SERGIO | Chief Executive Officer | Buy | $599.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 6 | - |
| 2025 Q3 | 3 | - |
| 2025 Q2 | 8 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | 8 | - |
RLMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools